Dopamine Support in Shock

Mechanism (dose-dependent receptor activity)

• Fischer's Mastery of Surgery, 8th ed.
• LITFL Inotropes/Vasopressors reference

How to actually give it

1. Access: Give through a central venous line whenever possible - peripheral extravasation can cause tissue necrosis given the potent vasoconstrictor effect at higher doses.
2. Delivery: Continuous IV infusion via syringe/infusion pump, titrated to a hemodynamic endpoint (usually MAP ≥ 65 mmHg, or improved perfusion/urine output), not a fixed dose.
3. Titration: Start low (e.g., 2-5 mcg/kg/min) and titrate upward every few minutes based on response; effects shift from inotropic to vasopressor as the dose climbs above ~10 mcg/kg/min.
4. Monitoring: Continuous ECG (watch for tachyarrhythmias - dopamine causes more arrhythmias than norepinephrine), arterial line for BP if escalating doses, extremity perfusion/pulses (risk of digital ischemia at high doses), urine output.
5. Weaning: Taper gradually rather than stopping abruptly, since abrupt discontinuation can cause rebound hypotension.

Where dopamine fits in current shock management

• Not first-line in septic or cardiogenic shock. Norepinephrine is preferred as first-line vasopressor in both. The SOAP II trial (De Backer et al., NEJM 2010) found no overall mortality difference between dopamine and norepinephrine in undifferentiated shock, but dopamine caused significantly more arrhythmic events, and in the cardiogenic shock subgroup dopamine was associated with higher mortality - Current Surgical Therapy, 14th ed.; The Washington Manual of Medical Therapeutics.
• Specific niche use: Dopamine "should be considered instead of norepinephrine only in patients with relative or absolute bradycardia who have a low risk of tachyarrhythmias" (its chronotropic effect can be useful here).
• Pediatric septic shock: Epinephrine or norepinephrine is preferred as the initial vasoactive infusion; dopamine is reserved as an alternative "if these are unavailable," particularly for cold septic shock with poor contractility/low SVR - The Harriet Lane Handbook, 23rd ed.
• "Renal-dose" dopamine is not recommended. Multiple sources confirm low-dose dopamine (2-4 mcg/kg/min) does not prevent or improve acute kidney injury/renal failure in shock and is not recommended for renal protection - Goldman-Cecil Medicine; Brenner and Rector's The Kidney. Some data even suggest it can worsen renal function via natriuresis in acute shock states.
• Special situation - hypothermia-associated hypotension: low-dose dopamine (2-5 mcg/kg/min) can be considered if hypotension doesn't respond to fluids and rewarming - Harrison's Principles of Internal Medicine, 22nd ed.

Practical summary

Evidence check